Elucidating causative gene variants in hereditary Parkinson's disease in the Global Parkinson's Genetics Program (GP2)
The Monogenic Network of GP2 accelerates finding new genetic causes of Parkinson’s disease and understanding known causes by sequencing up to 10,000 patients globally, prioritizing underrepresented groups for diverse insights.
